Noticias de Eulerpool Ligand Pharmaceuticals

Ligand Pharmaceuticals Eulerpool-AFX

Ligand Pharmaceuticals Noticias de Acciones

Ligand Pharmaceuticals es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Ligand Pharmaceuticals.

• 12 de septiembre ·

  Thefly.com
  Jefferies biotech analyst holds an analyst/industry conference call
• 6 de septiembre ·

  Yahoo
  Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy
• 6 de septiembre ·

  Thefly.com
  Ligand, Travere Therapeutics receives full FDA approval for Filspari
• 6 de septiembre ·

  Seeking Alpha
  Travere gains on full FDA approval for kidney drug Filspari
• 27 de agosto ·

  Yahoo
  Insider Sale: President & COO Matthew Korenberg Sells 18,858 Shares of Ligand ...
• 20 de agosto ·

  Yahoo
  Ligand to Present at H.C. Wainwright 26th Annual Global Investment Conference
• 19 de agosto ·

  Seeking Alpha
  Small-cap and mid-cap Health Care has room to rally - Roth MKM
• 16 de agosto ·

  Benzinga
  Looking Into Ligand Pharmaceuticals's Recent Short Interest
• 15 de agosto ·

  Yahoo
  Ligand Pharmaceuticals (NASDAQ:LGND) Shareholders Should Be Cautious Despite Solid Earnings
• 15 de agosto ·

  Yahoo
  Private Capital's Strategic Moves Highlight Ligand Pharmaceuticals in Q2 2024